docetaxel anhydrous has been researched along with lactoferrin in 4 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (lactoferrin) | Trials (lactoferrin) | Recent Studies (post-2010) (lactoferrin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 6,692 | 280 | 2,310 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeengar, MK; Khan, W; Pooja, D; Singh, I; Sistla, R; Swami, R | 1 |
| Abd Elwakil, MM; Abdelmoneem, MA; Abdulkader, MA; Albericio, F; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Khattab, SN; Teleb, M; Zaky, A | 1 |
| Jana, P; Kondapi, AK; Muj, C; Mukhopadhyay, S | 1 |
| Abdel Monaim, SAH; Abdulmalek, SA; Albericio, F; Bahey-El-Din, M; Bekhit, AA; Elkhodairy, KA; Elmorshedy, YM; Elzoghby, AO; Ghareeb, DA; Khattab, SN; Sallam, MA; Teleb, M | 1 |
4 other study(ies) available for docetaxel anhydrous and lactoferrin
| Article | Year |
|---|---|
Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Topics: Animals; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Liberation; Drug Stability; Female; Lactoferrin; Mice; Nanoparticles; Particle Size; Radioligand Assay; Taxoids; Tissue Distribution | 2016 |
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Humans; Lactoferrin; Mice; Nanoconjugates; Nanoparticles; NF-kappa B; Pentacyclic Triterpenes | 2021 |
Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Humans; Lactoferrin; Male; Nanoparticles; Prostatic Neoplasms; Rats | 2023 |
Engineered Microencapsulated Lactoferrin Nanoconjugates for Oral Targeted Treatment of Colon Cancer.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Docetaxel; Drug Carriers; Drug Delivery Systems; Lactoferrin; Nanoconjugates; Nanoparticles; Rats | 2023 |